Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders

About this subject

• What you'll learn

  Upon completing this subject, the student should be able to:

  1. Identify and evaluate problems associated with psychiatric and neurological medications using an evidence-based approach.
  2. Critically evaluate psychiatric and neurological medication therapy using an evidence-based approach and accepted best clinical practice to devise and justify appropriate courses of action for therapeutic management.
  3. Employ evidence-based and contemporary clinical skills to conduct a clinical audit and demonstrate how this may influence pharmacy practice in the management of psychiatric and neurological diseases.
  4. Demonstrate effective written and oral presentation skills to explain contemporary issues associated with psychiatric and neurological medication therapy.

• Topics covered

• Description

• Assessments

• Textbooks

• About University of Tasmania

Entry requirements

Part of a degree

To enrol in this subject you must be accepted into one of the following degrees:

Elective

• TAS-CPH-GDI-2023 - Graduate Diploma of Clinical Pharmacy
• TAS-CPH-GCE-2023 - Graduate Certificate in Clinical Pharmacy

Prior study

You must either have successfully completed the following subject(s) before starting this subject, or enrol in the following subject(s) to study at the same time or prior to this subject:

• TAS-CSA721-Introduction to Advanced Clinical Pharmacy Practice

Additional requirements

No additional requirements

Study load

0.125 EFTSL

This is in the range of 10 to 12 hours of study each week.

Equivalent full time study load (EFTSL) is one way to calculate your study load. One (1.0) EFTSL is equivalent to a full-time study load for one year.

Find out more information on Commonwealth Loans to understand what this means to your eligibility for financial support.